When teacher Ellen Reich began treatment for multiple myeloma in 2014, a sequence of therapies approved by the U.S....
“Do you want to have fun?” Richard Pazdur, MD, director of the U.S. Food and Drug Administration (FDA) Oncology...
Immune checkpoint inhibitors have become part of the standard of care for more than 14 different cancer types, including...
As February gives way to March, we bring you the latest round of editors’ picks selected by the editors...
To kick off the new year, the editors of the 10 AACR journals highlighted two phase I clinical trials,...
The end of the year presents a unique opportunity to look back on recent accomplishments, take inventory of successes...
With Thanksgiving behind us here in the United States, the holiday season is in full swing. So, grab some...
As the candy supply dwindles, and the Halloween sugar rush tapers off, get re-energized by the latest edition of...
Factors such as a dense tumor microenvironment, a lack of precise symptoms, and hard-to-target genetic mutations make pancreatic cancer...
As we unpack our cardigans in anticipation of cooler weather here on the East Coast, we are taking a...
The editors of the 10 AACR journals have selected a handful of must-read articles from the July issues. The...